Long-term preference and ease of use of a novel dry powder inhaler with budesonide in comparison to a conventional inhaler in asthmatic children

D. Bellamy, For the Airmax Preference Investigators Group (Muscliffe, Bournemouth, United Kingdom)

Source: Annual Congress 2001 - Updates of asthma therapy in children
Session: Updates of asthma therapy in children
Session type: Thematic Poster Session
Number: 831
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Bellamy, For the Airmax Preference Investigators Group (Muscliffe, Bournemouth, United Kingdom). Long-term preference and ease of use of a novel dry powder inhaler with budesonide in comparison to a conventional inhaler in asthmatic children. Eur Respir J 2001; 16: Suppl. 31, 831

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Efficacy and safety of salbutamol delivered via a novel multidose dry powder inhaler in comparison with two conventional dry powder inhalers and a pMDI in asthmatic subjects
Source: Eur Respir J 2001; 18: Suppl. 33, 50s
Year: 2001

A study to evaluate the therapeutic equivalence of a new multidose budesonide dry powder inhaler with a conventional budesonide dry powder inhaler
Source: Eur Respir J 2001; 18: Suppl. 33, 156s
Year: 2001

Comparison of two dry powder inhalers containing budesonide in the treatment of asthma in children
Source: Eur Respir J 2002; 20: Suppl. 38, 500s
Year: 2002

Formoterol: a new pMDI CFC free formulation. Efficacy of the 12µg dosage versus a dry powder inhaler in moderate to severe asthmatic patients
Source: Eur Respir J 2003; 22: Suppl. 45, 284s
Year: 2003

Effect of switching from salmeterol/fluticasone dry powder inhaler to formoterol/fluticasone pressurized metered-dose inhaler in elderly asthma patients
Source: International Congress 2016 – Asthma management
Year: 2016


One-year height growth in children with asthma treated with inhaled budesonide delivered from a new dry powder inhaler.
Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children
Year: 2008

Oral manifestations in asthmatic patients using metered dose inhaler and dry powder inhaler
Source: International Congress 2019 – Innovations in primary care assessment and management
Year: 2019

Evaluation of acceptability, efficacy and safety of a novel dry powder inhaler in patients with persistent asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 70s
Year: 2007

Beclometasone/formoterol administered via extrafine dry powder inhaler in controlled asthmatic patients: Comparison with pMDI and beclometasone monotherapy
Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma
Year: 2012


Young children with asthma treated with budesonide inhalation suspension can successfully be transitioned to once-daily budesonide dry powder inhaler
Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma
Year: 2007


A novel NEXT DPI® dry powder inhaler and its use in asthmatic and COPD population
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I
Year: 2011

Comparative in vitro performance of the new drug aclidinium in a novel multidose dry powder inhaler
Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs
Year: 2013

How does the Novolizer fit into the choice of inhaler?
Source: Annual Congress 2005 - Asthma management - important issues
Year: 2005

Formoterol delivered by multi-dose dry powder inhaler (MDDPI) improves nocturnal asthma symptoms
Source: Eur Respir J 2005; 26: Suppl. 49, 50s
Year: 2005

Preference for novel soft mist inhaler over pMDI in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 88s
Year: 2004

Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability
Source: Eur Respir J 2002; 19: 246-251
Year: 2002



Salbutamol delivered via a new multi-dose dry powder inhaler is as safe and efficacious as a pressurised metered dose inhaler in children aged 6-12 years
Source: Eur Respir J 2002; 20: Suppl. 38, 501s
Year: 2002

The genuair® inhaler: a novel multidose dry powder inhaler for the delivery of various types of inhalation powder
Source: Annual Congress 2009 - New aspects of inhalation therapy
Year: 2009

Comparison of proficiency of pressurized metered dose inhaler (pMDI) use with asthma control
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008